Stay updated on Fruquintinib in Metastatic Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Fruquintinib in Metastatic Colorectal Cancer Clinical Trial page.

Latest updates to the Fruquintinib in Metastatic Colorectal Cancer Clinical Trial page
- Check6 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe web page has been updated to announce a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference0.6%
- Check27 days agoNo Change Detected
- Check49 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check56 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed descriptions of a clinical trial for metastatic colorectal cancer and the addition of a new version number. The name of the study director has also been updated.SummaryDifference26%
- Check70 days agoChange DetectedThe web page has been updated to reflect new timelines and methodologies related to the analysis of adverse events and efficacy of fruquintinib, including changes in the definitions of treatment-emergent adverse events (TEAEs) and the duration of study drug administration. Additionally, the revision number has been updated to v2.14.4.SummaryDifference14%
- Check78 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
Stay in the know with updates to Fruquintinib in Metastatic Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fruquintinib in Metastatic Colorectal Cancer Clinical Trial page.